🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-23
Trial ID
NCT00753649
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
This study evaluates the immunogenicity and safety of Infanrix hexa™ (DTPa-...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-16
Trial ID
NCT01353703
Treatments Being Tested
This study will evaluate the persistence of immunity to hepatitis B 10 to 1...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-07
Trial ID
NCT01138098
Treatments Being Tested
The aim of this study is to assess antibody persistence in infants who rece...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05-30
Trial ID
NCT01358825
Treatments Being Tested
The purpose of this booster study is to evaluate, in subjects primed in the...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-01
Trial ID
NCT00627458
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-13
Trial ID
NCT00426361
Treatments Being Tested
This study will assess the immunogenicity and reactogenicity of the candida...
Status
Completed
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT01277705
The purpose of this study is to assess the efficacy and safety of repeating...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-05
Trial ID
NCT00548171
Treatments Being Tested
The purpose of this study is to evaluate immunogenicity and safety of menin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01144663
Treatments Being Tested